Big Tech earnings show AI chip demand is still ‘insatiable’
Whatever Thursday’s broad market moves, one thing is clear after the latest megacap tech earnings reports.
The biggest takeaways from the Trump-Xi meeting — what the truce covers and what is still unclear
President Donald Trump said the rare earths agreement is a one year deal that will be “very routinely extended as time goes by.”
Meta’s spending outlook is sending the stock lower. Here’s what analysts had to say
Better-than-expected results from Meta Platforms were being overshadowed by worries around the company’s massive artificial intelligence spending plans.
Restaurant Brands earnings top estimates, fueled by Tim Hortons and international growth
The company’s international segment was the star of the quarter with 6.5% same-store sales growth.
Rare earth stocks rally as China delays export controls after Trump-Xi meeting
Shares of U.S.-listed rare earth miners rallied on Thursday after China agreed to delay the introduction of export controls.
Comcast beats earnings estimates despite more broadband subscriber losses
Comcast said it lost 104,000 broadband customers during the period – the fourth quarter in a row it failed to grow its broadband subscriber base.
Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar
The results come as Eli Lilly works to maintain its edge over Novo Nordisk in the booming market for a class of obesity and diabetes drugs called GLP-1s.
Stock futures slide as Meta and Microsoft fall after earnings: Live updates
Megacap tech giants Alphabet, Meta and Microsoft each reported quarterly results after market close Wednesday.
Euro zone economy ekes out 0.2% growth after a helping hand from France
Economists polled by Reuters had anticipated the bloc’s economy to expand by 0.1% between July and September.
Novo Nordisk hijacks Pfizer with bid for U.S. biotech Metsera
Denmark’s Novo Nordisk said on Thursday it has made an unsolicited bid for U.S. drug maker Metsera, after Pfizer last week made an offer for the company.